StockWatch
·
Biotechnology: Pharmaceutical Preparations
RegulatoryJul 20, 2026, 06:31 AM

Rockwell Medical Regains Compliance with Nasdaq Listing Requirements

AI Summary

Rockwell Medical, Inc. announced it has regained compliance with The Nasdaq Stock Market LLC's minimum $1.00 per share bid price requirement for continued listing. The company maintained a closing bid price of $1.00 or greater for 10 consecutive business days, from July 1 to July 15, 2026. As a result, Nasdaq has closed the compliance matter, and Rockwell Medical is now in full compliance with all Nasdaq listing requirements.

Key Highlights

  • Rockwell Medical regained compliance with Nasdaq's minimum $1.00 bid price requirement.
  • The company maintained a minimum closing bid price of $1.00 or greater from July 1 to July 15, 2026.
  • Nasdaq considers the compliance matter closed.
  • Rockwell Medical is now in full compliance with all Nasdaq continued listing requirements.
  • The company's stock remains listed and traded on the Nasdaq Capital Market under RMTI.